Nantes-Saint Herblain, France, May 19th, 2022 – Naogen Pharma, a winner of the government recovery plan (GO Radiopharma project), developing an innovative radiopharmaceutical molecular imaging solution to assess regional myocardial perfusion in adult patients with known or suspected coronary artery disease, announced today the appointment of Nicolas Cherrier as Managing Director.

Read the full press release by clicking here